Lakewood-Amedex Inc. today announced that Douglas Manion, M.D., FRCP (C), who has served as a board director since 2021, was named Chairman of...
Lakewood-Amedex Inc. today announced that Peter B. Corr, Ph.D., who has served as board chairman since 2020, was named Executive Chairman and will...
Lakewood-Amedex’s Second Clinical Trial for DFU Using New Nu-3 Gel Formulation Top Line Results Expected in December 2022 SARASOTA, Fla., April 5, 2022 -...
Elects Thomas Pfisterer and Douglas Manion, MD, FRCP(C), to the Board of Directors SARASOTA, Fla., January 25, 2022 — Lakewood-Amedex Inc., a privately held, clinical stage...
Lakewood-Amedex Therapeutics Inc. today announced that Peter B. Corr, Ph.D., has been elected as Chairman of the Board of Directors of the company. Dr....